ArticleBiomarker research2025

Early kinetics of serum amyloid A predict clinical benefit to first-line chemoimmunotherapy and immunotherapy in advanced non-small cell lung cancer: a retrospective analysis.

Wei Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.